Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Krystal Biotech (KRYS) Return on Capital Employed (2021 - 2025)

Krystal Biotech (KRYS) has disclosed Return on Capital Employed for 5 consecutive years, with 0.14% as the latest value for Q4 2025.

  • Quarterly Return on Capital Employed rose 6.0% to 0.14% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 0.14% through Dec 2025, up 6.0% year-over-year, with the annual reading at 0.15% for FY2025, 7.0% up from the prior year.
  • Return on Capital Employed hit 0.14% in Q4 2025 for Krystal Biotech, down from 0.14% in the prior quarter.
  • In the past five years, Return on Capital Employed ranged from a high of 0.14% in Q3 2025 to a low of 0.28% in Q1 2023.
  • Historically, Return on Capital Employed has averaged 0.08% across 5 years, with a median of 0.13% in 2021.
  • Biggest five-year swings in Return on Capital Employed: dropped -14bps in 2022 and later rose 24bps in 2024.
  • Year by year, Return on Capital Employed stood at 0.13% in 2021, then plummeted by -103bps to 0.27% in 2022, then soared by 47bps to 0.14% in 2023, then surged by 150bps to 0.07% in 2024, then surged by 90bps to 0.14% in 2025.
  • Business Quant data shows Return on Capital Employed for KRYS at 0.14% in Q4 2025, 0.14% in Q3 2025, and 0.14% in Q2 2025.